St Charles Pharmaceuticals stcharlespharma.com


Public lists: Pharma Startups (4732)

St Charles Pharmaceuticals, Inc. is a CNS drug development company exploiting approaches to therapeutic intervention by targeting the crossover of signaling pathways for pain and neuro-inflammation. The company's lead clinical candidate, SCP-123 (IND Enabling), is efficacious and safe in non-clinical studies, and is one of a series of safer and more potent non-opiod analgesics discovered by the company's founder, Dr. Nicolas Bazan. SCP's focus is translating early-stage compounds into clinical...Show all

St Charles Pharmaceuticals, Inc. is a CNS drug development company exploiting approaches to therapeutic intervention by targeting the crossover of signaling pathways for pain and neuro-inflammation. The company's lead clinical candidate, SCP-123 (IN...Show all

Company (Alive / Active)

Phone:

Fax:

Alachua, 32615
Florida, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
St Charles Pharmaceuticals $0M Nov 30, 2018
See all 16 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related St Charles Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Activate Immunotherapy

San Diego, California, United States
Alive / ActiveActivate Immunotherapy (formerly NovaRx) is a clinical-stage immuno-oncology company based in San Diego, California. Activate utilizes a novel approach for activating the body's immune system to recognize and destroy cancer cells. The company's most advanced immunotherapy, Lucanix, has been tested in late stage clinical trials as a treatment for non-small cell lung cancer (NSCLC), the largest cancer indication in the world. Lucanix has promising Phase 2 and Phase 3 data. In Lucanix's Phase 2 tri...Show allLogin to see details

QuatRx Pharmaceuticals

Ann Arbor, Michigan, United States
Alive / ActiveQuatRx Pharmaceuticals Company is focused on discovering, licensing, developing and commercializing compounds in the endocrine, metabolic and cardiovascular therapeutic areas. In addition to QRX-431, QuatRx currently has three product candidates in clinical development. QuatRxLogin to see details
See all 16 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)